证券代码：688478 证券简称：晶升股份 公告编号：2025-031 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 是否涉及差异化分红送转：是 ? 每股分配比例 每股现金红利0.25元 ? 相关日期 股权登记日 除权（息）日 现金红利发放日 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 5 月 20 日的2024年年度股东大会审议通过。 二、 分配方案 （1）差异化分红方案 根据公司 2024 年年度股东大会审议通过的《关于 2024 年年度利润分配预案 的议案》 ，公司拟以实施权益分派股权登记日登记的总股本（扣除回购专用证券账 户的股份数）为基数，向全体股东每 10 股派发现金红利人民币 2.50 元（含税）， 不送红股，不进行资本公积转增股本。如在分配方案披露之日起至实施权益分派 股权登记日期间因新增股份上市、股份回购等事项导致公司总股本发生变化的， 则以未来实施分配方案的股权登记日的总股本扣减回购专用证券账户中股份数为 基数，按照每股分配比例不变的原则对分配总额进行调 ...

证券代码：688237 证券简称：超卓航科 公告编号：2025-035 湖北超卓航空科技股份有限公司 重要内容提示： ? 是否涉及差异化分红送转：是 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 16 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东 （公司回购专用证券账户除外）。 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 ? 每股分配比例 每股现金红利0.34元（含税） ? 相关日期 股权登记日 除权（息）日 现金红利发放日 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上海证券交易 所上市公司自律监管指引第 7 号——回购股份》等相关法律、行政法规、部门规 章及其他规范性文件和《公司章程》的有关规定，公司回购专用证券账户中的股 份不享有股东大会表决权、利润分配、公积金转增股本、认购新股和可转换公司 债券等权利。 （1）本次 ...

Core Viewpoint - Haidilao is innovating by launching themed restaurants, such as the new "Crispy Fish" concept in Guangzhou, to differentiate itself in a saturated market [1][2][4]. Group 1: Thematic Store Launches - Haidilao has opened a "Crispy Fish Fresh Cut Theme Store" in Guangzhou, marking a significant departure from its traditional offerings [2]. - The new store features a glass fish tank and a visible kitchen where chefs prepare dishes on-site, enhancing customer experience [2][11]. - The introduction of regional specialties like "Crispy Fish" from Zhongshan aims to expand the brand's reach beyond local markets [4][6]. Group 2: Market Trends and Challenges - The overall market growth for the hot pot industry is slowing, with a projected increase of only 5.6% in 2024 compared to 19.9% in 2023 [7]. - The number of hot pot restaurants peaked in November but has since declined, indicating a competitive and saturated market [7][9]. - Haidilao's strategy of localized menu adjustments and thematic innovations is a response to changing consumer demands and market conditions [10][13]. Group 3: Innovation and Differentiation - Haidilao's approach emphasizes fresh ingredients and regional flavors, with a focus on local supply chains to create unique offerings [9][10]. - The company has launched multiple themed stores across 24 cities, with a total of 42 fresh-cut kitchen theme stores, showcasing its commitment to innovation [6][12]. - Other brands in the industry, such as Banlu and Coucou, are also exploring unique offerings and localized themes to stand out in the competitive landscape [15][18]. Group 4: Future Directions - Haidilao plans to expand the successful "Crispy Fish" concept to more locations if the initial response is positive, indicating a potential nationwide rollout [4][12]. - The company is leveraging data and customer feedback to continuously adapt its menu and offerings, ensuring relevance in a dynamic market [10][13]. - The trend towards "fire pot +" models, integrating different dining experiences, is becoming more prevalent among major brands [19][20].

Core Viewpoint - Haiyang Technology Co., Ltd. has successfully transitioned from traditional chemical fibers to modern nylon materials, establishing a comprehensive product system for Nylon 6, with projected revenue exceeding 5.5 billion yuan in 2024 [1] Company History - The history of Haiyang Technology dates back to the 1970s, evolving from the Taizhou Synthetic Fiber Factory to its current form, navigating through various ownership and operational challenges [2] - In 1998, the company faced significant financial difficulties, prompting a turnaround plan that focused on low-cost expansion and capacity enhancement [2] Development Strategy - The current development strategy of Haiyang Technology emphasizes "differentiation, high-level, and large-scale" production, aiming to create unique products that enhance value [3] - The company believes that being "large and strong" is essential for survival in the manufacturing sector, particularly for basic materials [3] Product Applications - Nylon 6 produced by Haiyang Technology is utilized in various applications, including textiles, engineering plastics, and food packaging, with a total capacity of nearly 350,000 tons [4] - The company supplies raw materials to notable clients in the fiber and engineering plastics sectors, including BASF and Linglong Tire [4] Innovation and R&D - Haiyang Technology has developed a robust R&D system, holding 35 patents and being recognized as a "National Intellectual Property Advantage Enterprise" [4] - The company has established a unique product value chain by integrating research outcomes from academic institutions and its own R&D efforts [5] Smart Manufacturing - The company has implemented smart manufacturing solutions to address industry challenges, including high labor intensity and environmental concerns [5] - Haiyang Technology is committed to green and intelligent production processes, enhancing both efficiency and social responsibility [5] Corporate Culture and Values - The corporate values of Haiyang Technology include "dedication, innovation, efficiency, and win-win," with a focus on continuous improvement and employee welfare [6] - The company prioritizes talent acquisition and development as a key factor for its growth and project success [6] Future Goals - Haiyang Technology aims to become a centennial enterprise, with its recent IPO serving as a new starting point for this ambition [7] - Future efforts will focus on expanding quality customer bases, innovating differentiated products, and enhancing high-level production capacity [7]

Group 1 - The tourism market is experiencing a peak in bookings as summer approaches, with university students leading the demand for travel [1] - Graduation travel is particularly popular, with a notable increase in bookings for graduation travel products from June 9 to 11, with major cities like Beijing, Shanghai, Chengdu, and Guangzhou being popular departure points [1] - Theme parks are the most favored travel option among graduates, with Shanghai Disneyland, Beijing Universal Resort, and Hong Kong Disneyland ranking as the top three in terms of bookings [1] Group 2 - The average price of domestic and international flights has been steadily increasing, with a significant rise expected in July, prompting travelers to adjust their travel plans to avoid peak times [1] - Airlines are responding to the high demand by adding new routes, such as China Southern Airlines launching direct flights from Harbin to Vladivostok and Guangzhou to Almaty, increasing their international and regional routes to 150 [1] - Data indicates that university students are trying to travel earlier to avoid the peak of middle school students' travel, with family-oriented destinations expected to account for over 60% of summer consumption [1] Group 3 - The outbound tourism market is recovering due to improved visa accessibility, restored flight capacity, and optimized supply chains, with popular short-haul destinations including Japan, UAE, and Southeast Asia [2] - Hotel bookings for outbound travel have expanded to cover 1,788 cities globally, an increase of 375 cities compared to last year, with some popular destinations seeing hotel booking increases of nearly 70% year-on-year [2] - The tourism market is shifting from a focus on "traffic competition" to "price restructuring," emphasizing quality, personalization, and differentiation as key competitive factors [2] Group 4 - The summer tourism market is expected to fully recover and undergo structural upgrades by 2025, with family-oriented travelers becoming a core driving force [3] - The market will exhibit three main trends: a focus on family travel, prominent themed experiences, and an increase in demand for deep experiential travel [3] - These changes are anticipated to present new opportunities and challenges for the tourism industry [3]

Group 1 - The core point of the article is that Aopumai's acquisition of Pengli Bio reflects the collective anxiety within the biopharmaceutical industry, as both companies face performance pressures, making the merger appear as a means of mutual support during an industry downturn [2][7] - Aopumai plans to acquire Pengli Bio for 1.451 billion yuan, using a combination of cash and shares, with the board approving the proposal by a vote of 6 to 1, where the dissenting vote raised concerns about the necessity of the acquisition at this stage [2][3] - The acquisition features a differentiated valuation pricing model, where different types of shareholders receive varying valuations based on their roles and risk exposure, which is a departure from the traditional single valuation approach [3][4] Group 2 - Approximately 15 investors in the acquisition face a situation where the acquisition price corresponds to a valuation lower than their investment valuation, indicating a significant drop in value [4][11] - The acquisition valuation of 1.451 billion yuan represents a 54.94% decrease from Pengli Bio's pre-IPO financing valuation of 3.22 billion yuan, highlighting a significant decline in perceived value [11] - Aopumai's core business has shown a revenue increase of 22.26% to 297 million yuan in 2024, but the net profit has decreased by 61.04% to 21.05 million yuan, indicating underlying financial challenges [8][10] Group 3 - Both Aopumai and Pengli Bio are positioned within the CXO industry, facing similar growth challenges and complementing each other's business models, which enhances the strategic rationale for the merger [7][13] - The acquisition includes a performance commitment mechanism where 31 shareholders are involved, requiring Pengli Bio to achieve specific profit targets over the next three years, which adds a layer of accountability to the transaction [6][12] - The independent director's dissenting vote signals a cautious approach to the transaction, questioning the strategic necessity and potential financial burden of the acquisition on Aopumai [2][13]

安理法意2025字 0523 第 0001 号 致：温州市冠盛汽车零部件集团股份有限公司 北京市安理律师事务所（以下简称"本所"）接受温州市冠盛汽车零部件集 团股份有限公司（以下简称"公司"）的委托，根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券 法》"）、《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引 第7号—回购股份》等法律、 法规和规范性文件以及《温州市冠盛汽车零部件集 团股份有限公司章程》（以下简称"《公司章程》"）的规定，本所受温州市冠 盛汽车零部件集团股份有限公司（以下简称"公司"）委托，就公司2024年度利 润分配涉及的差异化权益分派特殊除权除息（以下简称"本次差异化分红"）的 相关事宜，出具本法律意见书。 为出具本法律意见书，本所律师依据现行法律、法规及规范性文件的规定和 要求，对本次差异化分红所涉及的重大法律事项进行了核查。 公司向本所保证，其已经提供了本所律师认为出具本法律意见书所必需的、 真实的原始书面材料、副本材料或者口头证言，并保证上述文件和证言真实、准 确、完整，不存在虚假记载、误导性陈述及重大遗漏；上述文件上所有 ...

Core Viewpoint - The legal opinion from Beijing DeHeng Law Offices confirms that the differentiated dividend distribution plan of Jianzhijia Pharmaceutical Chain Group Co., Ltd. complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [6]. Group 1: Reasons for Differentiated Dividend - Jianzhijia held its sixth board meeting on June 20, 2024, approving a share repurchase plan using self-owned funds to maintain company value and shareholder rights, with 1,143,260 shares repurchased by the announcement date [2]. - A subsequent board meeting on September 19, 2024, approved another share repurchase plan, resulting in an additional 903,400 shares repurchased [4]. - On October 29, 2024, a third board meeting approved a plan to repurchase 4,338,200 shares, totaling 6,384,860 shares that will not participate in profit distribution [4]. Group 2: Differentiated Dividend Plan - The company plans to distribute a cash dividend of RMB 11.00 per 10 shares (including tax) based on the total share capital minus the repurchased shares, resulting in a total of 162,973,874.80 RMB to be distributed [5]. - The total share capital as of the legal opinion date is 154,542,928 shares, with 6,384,860 shares excluded from the distribution, leading to 148,158,068 shares participating in the dividend [5]. Group 3: Calculation Basis for Differentiated Dividend - The reference price for ex-dividend is calculated as approximately 22.0500 RMB per share, based on the closing price of 23.15 RMB minus the cash dividend [5]. - The virtual distribution calculation shows a minor impact on the ex-dividend reference price, estimated at approximately 0.2059% [5]. Group 4: Conclusion - The legal opinion concludes that the differentiated dividend distribution plan is in accordance with the Company Law, Securities Law, and relevant regulations, ensuring no detriment to the company or its shareholders [6].

北京市金杜（广州）律师事务所 关于大参林医药集团股份有限公司 专项法律意见书 致：大参林医药集团股份有限公司 北京市金杜（广州）律师事务所（以下简称本所）受大参林医药集团股份 有限公司（以下简称公司）委托，根据《中华人民共和国公司法》（以下简称 《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）、《上市 公司股份回购规则》（以下简称《回购规则》）、《上海证券交易所上市公司 自律监管指引第 7 号——回购股份》（以下简称《监管指引第 7 号》）、《上 海证券交易所股票上市规则》等中华人民共和国境内（为本法律意见书之目的， 不包括中华人民共和国香港特别行政区、中华人民共和国澳门特别行政区和中 华人民共和国台湾地区）现行有效的法律、法规和规范性文件的规定以及《大 参林医药集团股份有限公司章程》，就公司 2024 年度利润分配所涉及的差异 化权益分派（以下简称本次差异化权益分派）相关事项，按照律师行业公认的 业务标准、道德规范和勤勉尽责精神，出具本法律意见书。 本法律意见书的出具已得到公司如下保证： 准确、完整和有效的，且一切足以影响本法律意见书的事实和文件均已向本所 披露，而无任何隐瞒或重大遗漏。 印件或 ...

浙江天册律师事务所 关于 浙江九洲药业股份有限公司 法律意见书 浙江省杭州市杭大路 1 号黄龙世纪广场 A 座 11 楼 310007 电话：0571-87901111 传真：0571-87901500 法律意见书 浙江天册律师事务所 关于 浙江九洲药业股份有限公司 法律意见书 编号：TCYJS2025H0852 号 致：浙江九洲药业股份有限公司 浙江天册律师事务所（以下简称"本所"）接受浙江九洲药业股份有限公司（以 下简称"九洲药业"或"公司"）的委托，就公司 2024 年度利润分配方案所涉及 的差异化权益分派（以下简称"本次差异化权益分派"）相关事宜，根据《中华人 民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国公司法》（以 下简称"《公司法》"）、《上市公司股份回购规则（2025 修订）》（以下简称 "《回购规则》"）和《上海证券交易所上市公司自律监管指引第 7 号——回购股 份（2025 年 3 月修订）》（以下简称"《自律监管指引第 7 号》"）等有关法律、 法规和有关规范性文件，出具本法律意见书。 第一部分 声明事项 为出具本法律意见书，本所及本所律师声明如下： 一、为出具本法律意见书 ...